Research Study

ECOSPOR IV: An Open-Label Extension of Study SERES 0012 Evaluating SER-109 in Subjects With Recurrent Clostridium Difficile Infection
Principal Investigator 
Theodore Steiner

Overview

ClinicalTrials.gov# 
NCT03183141
Status 
Recruiting
Study Start/End 
Nov 28, 2018 to Aug 31, 2019
Locations 
Diamond Health Care Centre
Name/Title 
Jorell Gantioqui, Research Assistant
Phone 
604-875-4111 ext.62178
Purpose of Study 

The purpose of this study is to assess safety and efficacy of SER-109 in reducing recurrence of Clostridium difficile infection (CDI) in adults who had a CDI recurrence within 8 weeks after receipt of SER-109 or Placebo in Study SERES-012.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.